João, who graduated from Portugal’s Oporto University in 2009, was recruited from the University of Liverpool, where he was a lecturer in Small Animal Cardiology.
Willows Clinical Director Toby Gemmill said: "This is an exciting time for us. As part of our new extension, our state-of-the-art cardiology suite is now open and fully operational, while we have also appointed a hugely knowledgeable and experienced cardiologist to join the team.
"It is further evidence of our continued commitment to invest in top talent and the best facilities so we can provide the highest standards of care and treatment."
João said: "I’m very pleased to have joined a centre of excellence like Willows and to be working in the fantastic new cardiology suite.
"I enjoy all aspects of medical and interventional cardiology but I have a particular interest in feline cardiomyopathies, cardiorenal syndrome and atrial fibrillation."
Josep Aisa has arrived from Glasgow University, where he spent four years as a lecturer focusing on soft tissue procedures. He has authored numerous scientific papers and given presentations to international veterinary meetings, specifically on orthopaedic conditions.
Josep has a keen interest in oncological surgery and also boasts a broad area of expertise including orthopaedics.
Veronica Mortera has just finished a three-year residency in Neurology and Neurosurgery at Bristol University where she specialised in spinal surgery and inflammatory diseases of the brain. In 2014, she completed an internship in Small Animal Medicine and Surgery at Glasgow University where she authored a paper on MRI abnormalities in dogs with portosystemic shunts.
Veronica also spent three months in Geneva with the World Health Organization helping in the development of Public Health guidelines.
Joining Veronica in the neurology department is Francesca de Strobel, who earned a PhD from the University of Padua, in Italy, after writing a thesis on intervertebral disc degeneration in a large animal model.
Francesca began work as a Small Animal Veterinarian and Clinical Assistant in Neurology at the University’s Veterinary Teaching Hospital before moving to the UK in 2014 to begin an internship in neurology at Dick White Referrals, where she completed a three-year residency programme in small animal veterinary neurology and neurosurgery.
She enjoys all aspects of neurology and neurosurgery, with a particular interest for spinal surgery, metabolic and intracranial disorders.
North Downs is also extending its facilities with new consultation rooms, extra theatre and procedure rooms, more kennels, new staff facilities and extended vet space, along with a new meeting room. It is also creating a central imaging suite, with new MRI and CT scanners.
Hospital director Terry Emmerson said: "These are very exciting times at NDSR as work on the new extension begins and the plans actually start to take shape.
"It’s definitely a powerful illustration of our commitment to offer the very best service possible to all our patients, both in terms of facilities and equipment and in our clinical care."
Photo: From left, Veronica Mortera, Josep Aisa and Francesca de Strobel
The company says the masterclass will equip veterinary surgeons with an understanding of how TPLO fits into the range of treatments for one of the commonest causes of serious hindlimb lameness in the adult dog: cranial cruciate ligament failure.
The course will take place on 13 and 14 September at Improve’s HQ, Alexandra House, Swindon, and will be led by Dr Steve Butterworth, MA VetMB CertVR DSAO MRCVS and RCVS Specialist in Small Animal Surgery (Orthopaedics).
Improve’s Veterinary Operations Manager Juliet Pope MRCVS, said: "We are delighted to offer this new masterclass, created for a maximum of ten delegates to ensure true one-to-one tutoring, and we thank the team at Freelance Surgical for supporting its development.
"The combination of lectures and practical sessions led by Steve Butterworth will revise relevant surgical anatomy to enable delegates to undertake TPLO procedures with confidence. We are particularly pleased to be able to offer radiography as an integral part of the course so that delegates can see the results of their new surgical skills before taking them back to their clinics."
The survey polled 671 veterinary surgeons in May and June 2017.
92% of those who are now in non-clinical roles had worked in clinical practice in the past. 73% had previously worked in mixed practice, 49% in companion animal practice, 33% in production animal practice and 8% in equine practice.
32% are now in academia, whilst 21% have moved to work in commerce and industry.
Mostly, veterinary surgeons gave positive reasons for moving to non-clinical work: 43% said they were looking for a new challenge and 33% said they were looking for a different type of work.
Others were looking to improve their work-life balance: 24% said they wanted a role with no out-of-hours work, 14% said they wanted more flexible working hours and 10% said clinical work was incompatible with family or outside commitments.
21% cited difficulty in progressing with their clinical career as a reason for moving whilst 19% said they were looking for less stress at work.
There were some differences between men and women in the timing of their career change and the reasons behind it. Women tended to leave clinical practice earlier in their career; an average of 6.5 years after they qualified compared to 8 years for men.
Reasons related to working hours and flexibility were more prominent motivations for women to move from clinical practice (54% of female vets compared to 31% of male vets). On the other hand, male vets were more likely than female vets to cite reasons related to a desire to do a different type of work (44% of male vets compared to 24% of female vets).
BVA Senior Vice President, Gudrun Ravetz said: "These figures show that there is a sizeable percentage of practising vets who are making the move into non-clinical roles and that there are a variety of reasons behind their decision. There is a huge diversity of career paths open to vets and it’s important both for those who are already in practice and for those considering a veterinary career to be aware of all the options available.
"I have had a portfolio career myself that involved clinical practice in all different business models including charity practice and industry and I know that the most important thing is for vets to feel fulfilled in their chosen roles and understand that there is a wide range of opportunity available to them.
"However, we also know that practices are seriously worried about being able to recruit and retain staff. Looking at the reasons for leaving – including a desire for more flexibility, a better work/life balance, and concerns about stress – this has to be a wake-up call to all employers to think about whether we can do things differently to support our colleagues.
"BVA has a role to play too and many of the Vet Futures actions are designed to address these issues, including the workforce study commissioned by BVA, the development of a careers hub, and our support for the Mind Matters Initiative led by RCVS, amongst others. These are issues that the profession must tackle together."
Tim Harrison, managing director at White Cross Vets, said: "Our plan has been to open five new practices within a 12 month period and despite having a strong presence in West Yorkshire we didn’t have a practice in South Yorkshire. When we found out Dave wanted to move to Sheffield it made perfect sense for us to expand into the area and for him to lead the practice as clinic director.
"Dave is a hugely talented and compassionate professional and we certainly didn’t want to lose him. The Handsworth opening is the perfect fit for Dave who will lead a team of four. As the practice expands, we envisage that we will create a further 20 jobs over the next five years.”
White Cross says it has invested £250,000 in the practice, which is opening on the site of a former sausage factory which has recently been redeveloped at a cost of £1.1M.
Dave said: "I was so thrilled when Tim told me his plans for Sheffield. I love the area and my wife’s family have grown up there, I have been wanting to set up a long term family home for a while, and the fact that I have been able to move my young family to South Yorkshire, and still work for White Cross Vets, makes me really happy."
This was the sixth time that Mr Warwick Seymour-Hamilton had applied for restoration after being removed from the Register in June 1994, the reasons for which related to the condition of his practice premises and his record-keeping following an inspection by the RCVS. His most recent restoration hearing took place in May 2017.
In his application Mr Seymour-Hamilton said that he wanted to be restored to the Register to aid his research into herbal medicines and, during the course of the hearing, he also challenged some of the evidence given to the Committee in the June 1994 hearing. In particular he challenged the assertion that his practice was open when it was inspected by the RCVS as, he submitted that, he had retired three weeks’ prior to the inspection due to ill-health.
Mr Seymour-Hamilton told the Committee that he did not wish to return to clinical practice but wished to restore his membership of the RCVS in order to prescribe his own herbal treatments and to obtain peer review that would allow his treatments to be licensed. Furthermore, he produced, during the hearing, a continuing professional development (CPD) record card in which he had logged 1,438 hours of CPD in 2017.
In considering his application for restoration the Committee dismissed his challenge to the details of his original hearing in June 1994.
Ms Judith Way, Chairing the Committee and speaking on its behalf, said: "The Committee has noted that this issue is ancient. It is not for this Committee to consider it. Moreover the finding of the Committee represents a determination which was not challenged by the applicant until one of the more recent restoration applications. He never appealed it. Nor did he attend at the original hearing. It acknowledges that the premises could well have been closed given their condition, but whether they were or not is not for it [the Committee] to decide. It is quite possible the applicant has persuaded himself of the position. This is not an issue which is a persuasive factor in this application."
Regarding Mr Seymour-Hamilton’s contention that he would use his RCVS registered status to further his research into herbal treatments Ms Way said: "The Committee accepted there were no direct public protection issues which caused it concern, although it did retain some anxiety that the applicant’s commitment to herbal medicine could govern the way in which he would wish to care for an animal. A more rounded veterinary approach, which involved a full evaluation of an animal’s condition, a coherent diagnosis and a subsequent discussion about treatment with the client is called for."
Turning to his CPD she added: "His CPD now has a bias for herbal medicine as does his extensive reading. The Committee was not satisfied that his skills are up-to-date and that he could practise veterinary medicine safely. The Committee was not satisfied that he would approach a sick animal with the full and rounded approach required of a veterinary surgeon. Nor did his confidence in this regard allay the concerns of the Committee. He expressed belief in himself on the basis of his practice which came to an end some 24 years ago."
The Committee did acknowledge that Mr Seymour-Hamilton’s removal from the Register had a considerable impact on him and that, not only is he ashamed of it, but he believes it is frustrating his ability to advance the cause of herbal medicine.
In conclusion, Ms Way said: "Taking all these matters into account, the Committee has concluded that the applicant has not satisfied it on all of the evidence that he is fit to be restored to the Register and so this application is refused."
This, says Spillers, suggests that older horses, whether or not they have been diagnosed with insulin dysregulation, need an appropriate diet and management plan to help minimise the risks associated with insulin dysregulation such as laminitis.
The two studies1,2, which were conducted in collaboration with Michigan State University, aimed to find out more about the relationship between insulin dysregulation, dietary adaptation, and ageing to help guide more appropriate feeding regimens for senior horses.
Both studies investigated tissue insulin resistance and the insulin response in healthy adults compared to healthy senior horses adapted to diets with varying levels and sources of hydrolysable and structural carbohydrate (starch, sugar, and fibre).
Results from both studies showed insulin responses tend to increase with age in healthy horses, regardless of the diet they had been fed prior to evaluation. The insulin response, for example, was highest in the senior horses fed a starch rich meal even when they had been adapted to such a diet.
Clare Barfoot, RNutr, the research and development manager at Spillers said: "These studies confirm that even healthy older horses can have an increased insulin response compared to younger animals.
"This suggests that the energy sources used in the diet of senior horses and their effect on insulin dynamics need to be carefully considered.
"Practically, this means restricting the overall amount of starch and sugar in the diet especially for those horses that already have additional risk factors such as obesity, native breeding or PPID."
References
The results, in order of number of votes, are:
Elected: Susan Paterson – 3,976 votes
Elected: Mandisa Greene – 3,819 votes
Elected: Neil Smith – 3,544 votes
John Innes – 3,502 votes
David Catlow – 3,310 votes
Matthew Plumtree – 2,677 votes
Iain Richards – 2,635 votes
Karlien Heyrman – 2,487 votes
John Davies – 580 votes
Thomas Lonsdale – 542 votes
Due to the fact that a Legislative Reform Order (LRO) that amends the College’s governance has completed its passage through the House of Commons and House of Lords and is expected to be signed off by the relevant Minister to bring it into law, only the first three candidates are expected to take up their posts on Council at RCVS Day on 13 July 2018.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the election, said: "I would like to thank all the candidates who stood for Council this year and would like to, in particular, congratulate Susan, Mandisa and Neil for being re-elected to RCVS Council.
"The LRO that is likely to be signed off in due course will reconstitute the makeup of Council – with greater lay and veterinary nursing input – and will also reduce the overall size of Council, including the number of elected members. Because of this only the first three – as opposed to the first six under previous rules – candidates are likely to be taking up a four-year term at RCVS Day 2018. Our commiserations go out to all the unsuccessful candidates, especially in this unusual transitional year, and we thank them for their participation in this year’s election."
The results of the election will be formally declared at this year’s RCVS Day – the College’s Annual General Meeting and awards ceremony – which takes place at the Royal Institute of British Architects on Friday 13 July 2018.
The National Equine Health Survey is a snapshot survey, conducted by the Blue Cross in conjunction with the British Equine Veterinary Association during the month of May each year, sponsored by Dodson & Horrell and Zoetis. Last year 5,235 people took part and returned records for 15,433 horses.
The 2017 survey found that 39% of those who carry out faecal worm egg counts do so at four-monthly intervals, 22% do so at 8-12 week intervals and 2% do so at six-weekly intervals.
Dr Wendy Talbot, equine vet at Zoetis said: "The NEHS results show that there’s still a lack of understanding about the purpose and benefits of FWECs during the grazing season. For the most effective results FWECs should be conducted every 8 to 12 weeks between March and October. They will indicate which horses are passing the most worm eggs in their droppings and mean that horses are only treated when necessary.2 Remember though that FWECs don’t remove the need to treat horses at specific times of year for encysted small redworm, tapeworm and bots, none of which will show up in FWECs.3"
References:
The Adaptil Diffuser has been renamed the Adaptil Calm Home Diffuser, the Adaptil Collar has been renamed Adaptil Calm On-the-Go Collar, Adaptil Spray is now called Adaptil Transport and Adaptil Tablets are now called Adaptil Express.
The new products are split into three colour-coded groups. In blue packaging, Adaptil Calm Home Diffuser is designed to help dogs stay calm in recurring situations at home, including staying alone, loud noises and visitors. It comes as a 30-day starter kit containing a diffuser and refill, and lasts for 30 days.
Adaptil Calm On-the-go Collar is for use when dogs face fearful situations outdoors. It is available in two collar sizes (small to fit necks up to 37.5cm and large to fit necks up to 62.5cm) and it lasts for four weeks.
Adaptil Transport comes in yellow packaging and is designed to make travel and visits to the vet less stressful. It is available in 60ml and 20ml bottles.
Adaptil Calm Home Diffuser, Adaptil Calm On-the-Go Collar and Adaptil Transport all contain dog appeasing pheremones to help dogs feel calm and relaxed.
The last product in the new range is Adaptil Express, which comes in green packaging. Adaptil Express is an oral supplement which Ceva says provides a fast, calming effect for dogs faced with occasional challenging events such as thunderstorms and fireworks. The non-pheromone tablets, which come in packs of 10 or 40 tablets, combine GABA and amino acids and can be given with or without food.
Abigail King, product manager for Adaptil, said: "80% of pet owners state that their dog gets stressed during challenging situations both inside and outside the home and during specific occasions such as travelling, fireworks and thunderstorms1. Adaptil’s new product range caters for all these eventualities and the eye-catching branding and packaging clearly indicates which product should be used for each challenging occasion to aid owner compliance and help dogs feel calm and relaxed at all times."
For further information, visit www.adaptil.com/uk.
Reference
At present veterinary surgeons must destroy Schedule 2 controlled drugs in the presence of and directed by either an inspector appointed under the Veterinary Medicines Regulations, another veterinary surgeon independent of the practice where the destruction takes place, or a person legally authorised to witness the destruction of controlled drugs such as a Police CD Liaison Officer (CDLO).
This is something which may be helped by the launch of VetSurgeon Connect, a new map-based service on VetSurgeon.org designed to help members of the profession collaborate in a wide range of areas, including controlled drug disposal. VetSurgeon Connect is expected to launch next week.
Meanwhile, the VMD notes that there is a shortage of CDLOs and there are areas of the country where there are no local inspectors, or independent vets who can perform the task. Hence the survey to reveal the size of the problem.
The survey, which should take no more than 15 minutes, is open to all UK registered veterinary surgeons and closes on the 6th June. Here's the link: https://www.surveymonkey.co.uk/r/SHKTBYH
Any questions about the survey can be directed to: the VMD legislation team on 01932 338316 or controlleddrugssurvey@vmd.defra.gsi.gov.uk
Canergy contains propentofylline, a xanthine derivative which, Virbac says, potentiates the action of adenosine, a molecule found in the body which has a wide range of physiological effects which can be beneficial in the management of various age-related degenerative disease in dogs and cats1.
In particular, Virbac says propentofylline improves peripheral and cerebral vascular blood circulation, and has bronchodilating actions. This helps to increase oxygen supply to organs and muscles, which can result in a positive effect on overall demeanour and energy levels in older dogs.
Canergy is a beef-flavoured tablet which features SmartTab divisible design.
Canergy Product Manager Claire Lewis said: "Growing old should not have to be a barrier to enjoying life, so we are delighted to be able to add Canergy to the Virbac portfolio."
For more information, contact Virbac ob 01359 243243, email: enquiries@virbac.co.uk or visit: www.virbac.co.uk
IMV Technologies is a reproduction biotechnology company which has worked in the field of animal artificial insemination and embryo transfer for over 50 years, with operations in more than 130 countries and subsidiaries in the USA, India, China, Italy and the Netherlands.
The newly-formed IMV Imaging now has over 500 employees, which, it says, will make it better placed to deliver the best quality ultrasound, X-ray and three-dimensional veterinary-specific imaging equipment.
The directors and senior management team from BCF and ECM are remaining to lead IMV Imaging.
Alan Picken, CEO of IMV imaging said: "The merger and creation of IMV imaging is a very exciting development for our companies. Building on our strong legacy, it allows us to deliver a wider portfolio of products and services to our customers worldwide and ultimately to deliver improved animal care.”
1,219 farmers took part in the survey: 44% beef and 56% dairy. For the first time, the survey was also tailored for the regions. 488 responses came from famers in England, 380 from Scotland, 164 from Wales and 237 from Northern Ireland.
Boehringer Ingelheim’s Matt Yarnall, who led the project, said: "Headline findings are that farmers have regrets about holding onto persistently infected animals (PIs) which, at the end of the day, no-one should be doing.
"The financial benefit of being free of BVD was estimated as being over £90 per cow per year and when asked what impact BVD has had on their herd, the majority of producers highlighted poor fertility and high levels of disease in the herd.”
Boehringer says the identification of persistently infected animals (PIs) through tag and testing, supported by improved herd biosecurity and vaccination, could cost as little as £10 per cow per year, representing a significant return on investment for a disease with severe financial impact.
Matt said: "Herd biosecurity is also hugely variable. The most commonly selected response was operating a closed herd but, as most practitioners will know, the definition of a true closed herd and the real-life execution of that can be two very different things."
Highlighting one of the other major challenges for producers in cattle-dense areas, results from Scotland that showed that 51% of farmers with neighbouring cattle are worried about their neighbours' BVD status.
Matt said: "Perhaps the most alarming finding was the lack of awareness of the intricacies of some BVD vaccination courses, especially around when they need to be restarted, in order to achieve the protection needed."
2017 survey data from last year showed that 71% of producers were failing to achieve adequate protection when using a BVD vaccine that requires a booster six months after the primary course.
Boehringer says the results showed this is mostly down to not properly understanding the exact nature of the timings for the two-dose primary course, dates of service and calving and then the booster date.
Matt added: "For any practitioner advising clients, the 2018 finding that a shocking 85% haven’t restarted a vaccination course when the majority should have done, should ideally serve as a clear call to action."
For more information about the findings of the National BVD Survey, email bvdzero.uk@boehringer-ingelheim.com.
There will now be significant changes to the RCVS Council, as follows:
A gradual reduction in the number of elected members of RCVS Council from the current 24 to 13 by the year 2021.
A change of composition to include six lay members and two veterinary nurse members. Furthermore, the number of Council members appointed by each university whose veterinary degree is recognised by the RCVS will be reduced from two to one and Privy Council will no longer be required to appoint members. From 1 July 2020 university membership will undergo further changes as, from then on, veterinary schools will collectively appoint three members in total to serve on Council.
Members of Council will no longer be able to serve more than three consecutive four-year terms of office and, after serving three consecutive terms, they will not be eligible to re-stand as a candidate for two years.
Members of Council may be removed from office if they fail to satisfy any conditions about fitness to be a member, as determined by their peers on Council. If removed from office they will not be eligible to re-stand as a candidate for two years.
Introducing the LRO before the House of Lords last Tuesday, Lord Gardiner of Kimble said: "The proposed changes… reduce the size of Council and revise the balance of membership between vets and non-vets, including veterinary nurses and lay persons. They will bring the RCVS in-line with many other modern-day regulatory bodies and allow for greater efficiency, transparency and accountability to both members and the general public. For all the reasons I have outlined today, I commend the use of Legislative Reform Order to make changes that will benefit the veterinary profession."
The full text of the Legislative Reform Order can be found on www.legislation.gov.uk and the full transcript of the debate in the House of Lords can be found in Hansard Online (https://hansard.parliament.uk).
Professor Stephen May, RCVS President, said: "We have been looking at reform of Council as an issue of some urgency since 2013, in recognition of the fact that, with the formula-driven growth of Council, it was becoming unwieldy, which has an impact on the cost of each meeting and the frequency with which it could reasonably meet.
"This reform has been long in gestation and so we are glad that this has now been approved and that we can look forward to a more modern, agile and efficient governance structure, aimed as always at benefitting the professions, animal owners and animal health and welfare."
One immediate impact of the LRO relates to the results of this year’s RCVS Council election as the Ministerial sign-off now confirms that only the first three candidates (in order of number of votes) will take up their four-year terms at RCVS Day on Friday 13 July 2018. These are Susan Paterson, Mandisa Greene and Neil Smith, all of whom are current members who were re-elected.
The RCVS Veterinary Nurses Council agreed reforms to its own governance last year, including shortening the term of office from four years to three years; introducing a consecutive three-term limit for elected members; and, reducing the size and changing the composition of VN Council to six elected veterinary nurses, two appointed veterinary nurse members, two appointed veterinary surgeon members from RCVS Council, and four appointed lay members.
The company warned last year that Equip Artervac would be out of stock from the end of November 2017 until mid-2018, but says that the re-availability of the vaccine means many vaccinated stallions and teasers should now be able to have their six-monthly booster dose within the normal designated timeframe.
Equip Artervac is indicated for the active immunisation for horses against equine arteritis virus to reduce the clinical signs and shedding of virus in nasal secretions following infection.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
The first charge was that in April 2016, having examined a horse named Alfie on behalf of his owner, Mr Villar gave an opinion to the potential buyers but failed to make it clear that he had not undertaken a pre-purchase examination; failed to declare to the buyer that he had a conflict of interest with regard to the owner; and, failed to explain the pre-purchase examination process to the buyers.
The second charge was that, in July 2016, during a telephone conversation with the buyer, Mr Villar was dishonest and failed to provide clear and accurate information because he told the buyers that he had only been asked to trot Alfie to check he was sound when he had, in fact, carried out a more substantial examination.
The third charge was that Mr Villar had offered to either the owner or the buyer, or both, that he would prepare a veterinary insurance certificate in relation to Alfie when he knew he did not have sufficient records (eg the microchip or passport number) to do so.
The fourth charge was that Mr Villar failed to respond adequately to communications from the buyers about Alfie.
The Committee found that Mr Villar had not in fact carried out a pre purchase examination (“PPE”) and referred to guidance from the British Equine Veterinary Association which identified that pre-purchase examinations are carried out on behalf of buyers. It noted that in this case, Mr Villar had undertaken an examination on behalf of the owner. Accordingly, it did not find that Mr Villar had failed to explain the PPE process to the potential buyers.
However, the Committee did find that Mr Villar had failed to declare that he had a conflict of interest in regards to Alfie’s owner. The Committee said that Mr Villar should have told the buyer that he had been acting on behalf of the owner and was not a neutral party in the potential sale.
The Committee found all aspects of the second charge not proven, on the basis that it was not satisfied so as to be sure that Mr Villar had told the potential buyers that he had only been asked to trot Alfie and check that he was sound.
The Committee found all aspects of the third charge proven on the basis that, in an email sent to the College in March 2016, Mr Villar admitted that he did not have the sufficient records to prepare a veterinary insurance certificate.
The Committee found the fourth charge not proven on the basis that the buyers were not his clients. The Committee therefore concluded that he had no obligation to respond to them, and indeed could not do so in certain respects in order to preserve the confidentiality of his client.
The Committee then determined that the charges found proven, when taken individually or in combination, did not amount to serious professional misconduct.
Ian Green, chairing the Committee and speaking on its behalf, said: "The following mitigating factors were present in this case: the circumstances of the incident, the fact that there was no premeditation, the fact that he was requested by his client to advance an opinion to [the buyers] concerning Alfie and that his ill judgement was on the spur of the moment and the fact that he had no financial gain. These are all important factors. Likewise, the fact that he did not know that the [buyers] regarded him as their pre-purchase examination vet is an important matter.
"The respondent’s conduct was clearly against the principles of behaviour articulated by Mr Morley [who acted as an expert witness for the College] in his expert report and in his evidence. Nevertheless, the Committee does not find that in the particular circumstances of this case, namely being asked to speak to a potential purchaser without warning and without being made aware of the contractual arrangements which had been made between the respondent and [the owner], the respondent should not properly be the subject of a finding of disgraceful conduct in a professional respect."
The ten-minute online survey aims to gather a snapshot of horse health over the period of a week.
The results help to identify trends in endemic equine diseases and help the Blue Cross steer equine awareness, education and research.
This year the survey includes some welfare questions to help guide knowledge in response to what the charity calls 'the UK’s horse welfare crisis'.
The National Equine Health Survey is run by the Blue Cross in partnership with the British Equine Veterinary Association. Dodson and Horrell is helping to cover the costs of running the scheme.
Supporters of the survey include the British Horse Society, Horse Trust, Redwings and the Pony Club.
Medal-winning riders Mary and Emily King, and Yazmin Pinchen (pictured right) also support the survey.
Visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk to register and take part, which carries the chance of winning prizes including Star Lister Clippers, a Lister Adagio Trimmer and some Burford Ariat boots.
Ubroseal is licenced for the prevention of new intramammary infections throughout the dry period. In cows considered likely to be free of sub-clinical mastitis, the product can be used on its own in dry cow management and mastitis control.
Boehringer's veterinary adviser, Kath Aplin said: "Ubroseal features a flexi-cap to reduce the risk of teat canal damage and its unique longer plunger makes application more ergonomic and significantly easier for the farmer."
The launch coincides with the publication of a statement by an expert group convened by Boehringer1 which recommends the administration of an internal teat sealant at drying off to all cows on all farms.
For more information, contact: vetenquiries@boehringer-ingelheim.com.
The group, which was convened by Boehringer Ingelheim, made its recommendation in a poster published at the National Mastitis Council meeting in Arizona1, prior to the launch of Boehringer's new teat sealant, Ubroseal.
The poster added that those animals that are likely to be infected need to receive antibiotic dry cow therapy (ADCT) in addition to a teat sealant.
Boehringer says various studies have shown that using an ITS reduces the risk of new intramammary infections and reduces the risk of clinical mastitis after calving, pointing to a meta-analysis of published papers which showed a 25% reduced risk of new infections and a 29% reduced risk of clinical mastitis for cows receiving ITS plus ADCT compared with ADCT alone
Boehringer’s veterinary adviser, Kath Aplin said: "Against the backdrop of targets from RUMA to reduce antibiotic use in the dairy sector3, adopting ITS for all cows could significantly reduce the need for antibiotics. An increase in the use of ITS is included in the dairy sector targets.
"We estimate that, currently, around 29% of the national herd is dried off without an ITS, so there is huge room for growth4."
Kath added: "With a 300-cow US study showing that a week after drying off, 47% of teats had still not formed a keratin plug5 and a New Zealand study showing that one in 20 cows had teats that remained open for 60 days6, it is clear to see that delayed teat closure is a very real problem in many herds. Teats remaining open after dry off make the udder highly susceptible to infection and delayed teat closure exacerbates the risk of acquiring an intramammary infection post-dry off4."
The expert group also recommended developing a herd plan, classifying herds as low risk or high risk and having a different approach to each.
High risk herds will have had a bulk SCC of >250,000 cell/ml in at least two of the last six months, they may also have a problem with Strep. agalactiae or could be experiencing an unavoidable risk period (a new building for example).
The priority should be to improve udder health management during both the lactation and dry period and any decision to abandon ADCT should be made with care and a full risk assessment.
The group said that in reality, it may be prudent to continue blanket ADCT until udder health has improved.
The group’s recommendations for low risk herds (<250,000 cells/ml in four out of the last six months) were to actively strive towards selective ADCT, supported by ITS for all cows.
The full recommendations are published in the proceedings of the NMC1 or can be obtained from your local Boehringer Ingelheim representative.
Kath said: "It has long been established that the mammary gland is highly susceptible to infection in the dry period and that the majority of clinical mastitis in early lactation is picked up during the dry period.
"Moving towards selective ADCT may not be appropriate immediately for all producers. However, the use of ITS for all cows on all farms will reduce new infection rates, assisting in the drive towards improved udder health and reduced antibiotic use."
Photo: Curious cattle on farmland in Cornwall UK. Shutterstock/Shzphoto
Dr Berwyn Clarke, CEO of PBD Biotech, which developed the bacteriophage-based detection method, says this is significant step forward: "In situations where a farm has had an ongoing chronic bovine TB problem, APHA’s protocol offers a promising new approach to controlling the infection.
"Actiphage is now included within a series of measures that farmers can use in conjunction with their vet and with specific APHA approval as a means to improving their disease management strategy.
"For many farms that have been struggling for years it provides the first step to becoming TB free. This move by the APHA is a really positive step towards tackling this devastating disease."
Much of this new strategy, as part of a private TB eradication plan, has been driven by the success of Devon-based vet Dick Sibley, who incorporated Actiphage into a disease management strategy last Autumn to help clear a dairy herd that had been stricken with TB since 2012.
Dick said: "The approach of directly measuring the presence of live bacteria in the blood in just six hours is a totally different but complementary measurement to other technologies and has enabled enhanced testing, early detection and containment of the infected animals.
"We don’t have all of the answers yet, but it’s about predicting, preventing and managing what we can – and Actiphage has contributed greatly to the outcome we’ve been after for so long."
The Exceptional private use of non-validated tests for TB on cattle in England protocol enables any private veterinary surgeon to request APHA permission for exceptional use of Actiphage and the other non-validated tests, subject to certain criteria that include herd supplementary interferon-γ (IFN- γ) testing, discussions with the APHA Case Vet and the farmer’s written consent.
Berwyn added: "Actiphage is unique in directly detecting live mycobacteria in blood or milk, and it can also distinguish between a vaccinated and an infected animal - paving the way for new types of disease control when vaccines become available in the future.
"We are working with international governments, and the test is being trialled on bovine, ovine as well as exotic species, but we appreciate it is new to the UK market so we’re keen to answer any queries vets or farmers may have."
The new test will be profiled in the Innovation Hub at the Royal Norfolk Agricultural Show next month (27 & 28 June).
PBD Biotech says Actiphage will require further testing before it is officially approved for standard veterinary use in the UK, however under the APHA protocol it is now permitted for private use where herds have experienced persistent breakdowns and this will contribute to the evidence-base required for official validation by the OIE and acceptance by APHA.
Within this protocol, APHA has outlined a number of other non-validated tests that may be proposed for exceptional use in cattle herds with chronic breakdowns, including: the Actiphage assay, developed by PBD Biotech and Nottingham University; the Enferplex TB serological test, produced by Enfer Laboratories Ireland and approved in GB for use in camelids; and the Polymerase Chain Reaction (PCR) testing of faecal samples. APHA says this is not an exhaustive list and that the protocol covers any current or future non-validated tests for bovine TB.
The comparative intradermal tuberculin skin test and the IFN- γ blood test remain the only ante mortem tests currently approved for the statutory cattle TB testing programme in Great Britain.
The full Exceptional private use of non-validated tests for TB on cattle in England is available on the APHA Vet Gateway: apha.defra.gov.uk/vet-gateway/non-valid-tb-testing
According to the blurb, A Practical Approach to Diagnosis and Management of Cardiac Arrhythmias will support delegates in developing an analytical approach to electrocardiogram (ECG) trace interpretation and help them to identify bradycardias, narrow and wide complex tachycardias and to select appropriate management options. The course takes place on Thursday 20th September 2018.
Cardiac Emergencies in Small Animal Practice will equip delegates to select the latest techniques to diagnose and manage commonly presented cardiac emergencies. They will learn the theory and practical application of point-of-care ultrasonographic techniques for diagnosis of pleural effusion, pulmonary oedema, pericardial effusion and ascites. They will also develop Centesis techniques and improve their knowledge of Acute Heart Failure. The course takes place on Friday 21 September 2018.
Juliet Pope from Improve said: "Emergency cardiac care is an area of growing importance to first opinion practitioners. These two courses have been carefully designed to provide a comprehensive overview of the latest techniques and management approaches which delegates will be able to utilise immediately in practice."
For more information contact Improve on 01793 759159.
The company says that the effervescent tablet presentation was designed to significantly improve vaccination practices for poultry producers while maintaining reliable virus protection.
Boehringer says this dispensing form reduces the risk of stock solution contamination and, when compared to glass vials, the small blister packs make vaccine management safer for operators, take up less room in the fridge and reduce packaging waste by 90%.
HatchPak IB H120 NeO will be available shortly in packs of 10 tablets of 1000 doses or 10 tablets of 2000 doses.
Callum Blair, Boehringer Ingelheim Avian and Swine Brand Manager, said: "The addition of HatchPak IB H120 NeO to our NeO product portfolio is evidence of our continued investment in the poultry sector."
The protocol provides evidence-based best practice criteria so that hospitals and other health settings can introduce animals into the care environment.
By following it, the RCN says services will be able to ensure the safety of patients and health care staff as well as the animals and their owners, while allowing patients to reap the benefits that interaction with animals can bring.
Publication of the protocol was prompted by an RCN survey last year which found that although the majority of respondents thought animals were hugely beneficial to patients, most nurses said animals were not allowed in their workplace.
The survey found that nine out of 10 nurses believe animals can help improve the health of patients with depression and other mental health problems with 60% of respondents also acknowledging that animals can help speed patient recovery.
Amanda Cheesley, RCN Professional Lead for Long-term Conditions and End-of-Life Care, said: "Anyone who’s worked in this area can see the amazing impact animals have on the health of adults and children alike.
"However there are so many myths around the dangers of having animals in health care settings that most organisations are too concerned to try it out.
"This protocol will help to dispel these fears by supporting hospitals to include animals in the care they deliver in a safe and professional way.
"We hope that it will encourage all health services to consider how animals can help their patients and help us to remove the taboo from what is a really remarkable area of care."
The protocol has been welcomed by the British Veterinary Association. Simon Doherty, BVA Junior Vice President, said: "This new protocol highlights the importance of the bond between humans and animals. It also serves as a welcome reminder at the start of Mental Health Awareness Week of how caring for and interacting with ‘man’s best friend’ can help to relieve stress and enhance wellbeing and a sense of companionship.
"It’s positive that the working group consulted with a wide range of organisations on welfare and safety considerations in developing this protocol, as ensuring the wellbeing of both humans and animals in these settings is paramount. As a fellow member of the UK One Health Coordination Group, BVA is very pleased to see a joined-up and forward-thinking approach to this important area of work."
Photo: Therapy Dog Visiting Young Female Patient In Hospital, Monkey Business Images / Shutterstock
The improvements include a new cat ward designed to offer a quieter, more relaxing area away from other animals, and a new walk-in dog ward which will allow staff to treat larger breeds of dogs more easily. The intensive care unit has been expanded and the practice has developed a new chemotherapy area.
John Turkington, the partner at Scarsdale Vets responsible for overseeing the work said: "We are already really proud of the state-of-the-art facilities we have at Pride, but we are not complacent and that is why we have made this significant investment to improve our facilities and ultimately the services we offer our clients and patients. Patient comfort is paramount, which is why we’ve invested in an additional walk in ward for our larger breeds, and a new cat ward with a separate feline examination and treatment area."
As well as the changes to improve clinical care, the practice has also invested in its kennelling services, increasing the number of 'suites' for cats and dogs to stay in its 'hotel' areas whilst their owners go on holiday.
John added: "We want Pride to be recognised as one of the best veterinary hospitals in Europe and to make that a reality we have increased our ward capacity for patient comfort and clinical treatment areas, as well as improving facilities behind the scenes for our staff, to create a better working environment. Alongside that the improvements to our Pet Resort will also meet the growing demands from clients for those services."